Cervical cancer is a major public health problem worldwide. It is one of the most common cancers, both in terms of incidence and mortality, and ranks first in many developing countries. Cervical infection with oncogenic HPV subtypes is the main aetiological factor in cervical cancer. This factor is necessary for the development of high-risk lesions and cancer. The combination of primary and secondary prevention strategies increases the efficiency of any programme to combat cervical cancer.